Lineage Cell Therapeutics, Inc. Other Accrued Liabilities, Current
Lineage Cell Therapeutics, Inc. (LCTX) had Other Accrued Liabilities, Current of $37.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2023-05-11
- 2023-03-31: Other Accrued Liabilities, Current $37.00K.
- 2022-09-30: Other Accrued Liabilities, Current $25.00K.
- 2022-06-30: Other Accrued Liabilities, Current $10.00K.
- 2022-03-31: Other Accrued Liabilities, Current $78.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2023-03-31 | $37.00K 10-Q · filed 2023-05-11 | |
| 2022-09-30 | $25.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $10.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $78.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $178.00K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $69.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $492.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $179.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $9.00K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $5.00K 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $61.00K 10-Q · filed 2020-08-06 | |
| 2019-12-31 | $4.00K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $3.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $76.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $24.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $9.00K 10-K · filed 2020-03-12 | |
| 2018-06-30 | $102.00K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $292.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $137.00K 10-K · filed 2019-03-14 | |
| 2017-09-30 | $295.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $532.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $447.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $435.00K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $427.00K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $371.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $97.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $432.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $326.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $251.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $282.25K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $417.00K 10-K · filed 2016-03-15 | $417.32K 10-K · filed 2015-03-11 |
| 2014-09-30 | $2.82M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $2.65M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $2.69M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $391.73K 10-K · filed 2015-03-11 | $2.23M 10-K · filed 2014-03-17 |
| 2013-09-30 | $1.75M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $2.28M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $2.44M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $2.32M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $1.45M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $1.60M 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $979.38K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |